These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 39062555)
1. Bile Acids as Emerging Players at the Intersection of Steatotic Liver Disease and Cardiovascular Diseases. Bilson J; Scorletti E; Swann JR; Byrne CD Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062555 [TBL] [Abstract][Full Text] [Related]
2. Role of the microbiota-gut-heart axis between bile acids and cardiovascular disease. Zhang Z; Lv T; Wang X; Wu M; Zhang R; Yang X; Fu Y; Liu Z Biomed Pharmacother; 2024 May; 174():116567. PubMed ID: 38583340 [TBL] [Abstract][Full Text] [Related]
3. Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob/ob mice. Park MY; Kim SJ; Ko EK; Ahn SH; Seo H; Sung MK J Appl Microbiol; 2016 Sep; 121(3):800-10. PubMed ID: 27111464 [TBL] [Abstract][Full Text] [Related]
4. Turnover of bile acids in liver, serum and caecal content by high-fat diet feeding affects hepatic steatosis in rats. Tang Y; Zhang J; Li J; Lei X; Xu D; Wang Y; Li C; Li X; Mao Y Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Oct; 1864(10):1293-1304. PubMed ID: 31170503 [TBL] [Abstract][Full Text] [Related]
5. Bile-ology: from bench to bedside. Jin LH; Fang ZP; Fan MJ; Huang WD J Zhejiang Univ Sci B; 2019 May; 20(5):414-427. PubMed ID: 31090267 [TBL] [Abstract][Full Text] [Related]
7. Targeting the alternative bile acid synthetic pathway for metabolic diseases. Jia W; Wei M; Rajani C; Zheng X Protein Cell; 2021 May; 12(5):411-425. PubMed ID: 33252713 [TBL] [Abstract][Full Text] [Related]
8. Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases. Guan B; Tong J; Hao H; Yang Z; Chen K; Xu H; Wang A Acta Pharm Sin B; 2022 May; 12(5):2129-2149. PubMed ID: 35646540 [TBL] [Abstract][Full Text] [Related]
9. Bile acid-mediated control of liver triglycerides. Fuchs C; Claudel T; Trauner M Semin Liver Dis; 2013 Nov; 33(4):330-42. PubMed ID: 24222091 [TBL] [Abstract][Full Text] [Related]
10. Soyasaponin A Xiong F; Zheng Z; Xiao L; Su C; Chen J; Gu X; Tang J; Zhao Y; Luo H; Zha L Mol Nutr Food Res; 2021 Jul; 65(14):e2100067. PubMed ID: 34047448 [TBL] [Abstract][Full Text] [Related]
11. Pemafibrate abrogates SLD in a rat experimental dietary model, inducing a shift in fecal bile acids and microbiota composition. Bentanachs R; Miró L; Sánchez RM; Ramírez-Carrasco P; Amat C; Alegret M; Pérez A; Roglans N; Laguna JC Biomed Pharmacother; 2024 Aug; 177():117067. PubMed ID: 38943989 [TBL] [Abstract][Full Text] [Related]
12. Amelioration of hyperglycaemia and hyperlipidaemia by adjusting the interplay between gut microbiota and bile acid metabolism: Radix Scutellariae as a case. Zhao L; Ma P; Peng Y; Wang M; Peng C; Zhang Y; Li X Phytomedicine; 2021 Mar; 83():153477. PubMed ID: 33545549 [TBL] [Abstract][Full Text] [Related]
13. The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer. Sun L; Cai J; Gonzalez FJ Nat Rev Gastroenterol Hepatol; 2021 May; 18(5):335-347. PubMed ID: 33568795 [TBL] [Abstract][Full Text] [Related]
14. Association between 12α-hydroxylated bile acids and hepatic steatosis in rats fed a high-fat diet. Hori S; Abe T; Lee DG; Fukiya S; Yokota A; Aso N; Shirouchi B; Sato M; Ishizuka S J Nutr Biochem; 2020 Sep; 83():108412. PubMed ID: 32534424 [TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma: Novel understandings and therapeutic strategies based on bile acids (Review). Luo W; Guo S; Zhou Y; Zhu J; Zhao J; Wang M; Sang L; Wang B; Chang B Int J Oncol; 2022 Oct; 61(4):. PubMed ID: 35929515 [TBL] [Abstract][Full Text] [Related]
16. Bile acid metabolism in health and ageing-related diseases. Li XJ; Fang C; Zhao RH; Zou L; Miao H; Zhao YY Biochem Pharmacol; 2024 Jul; 225():116313. PubMed ID: 38788963 [TBL] [Abstract][Full Text] [Related]
17. Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma. Song Y; Lau HC; Zhang X; Yu J Cancer Biol Med; 2023 Dec; 21(2):144-62. PubMed ID: 38148326 [TBL] [Abstract][Full Text] [Related]
18. Gender Differences in Bile Acids and Microbiota in Relationship with Gender Dissimilarity in Steatosis Induced by Diet and FXR Inactivation. Sheng L; Jena PK; Liu HX; Kalanetra KM; Gonzalez FJ; French SW; Krishnan VV; Mills DA; Wan YY Sci Rep; 2017 May; 7(1):1748. PubMed ID: 28496104 [TBL] [Abstract][Full Text] [Related]
19. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice. Li X; Zhao W; Xiao M; Yu L; Chen Q; Hu X; Zhao Y; Xiong L; Chen X; Wang X; Ba Y; Guo Q; Wu X J Ethnopharmacol; 2022 Aug; 294():115333. PubMed ID: 35500802 [TBL] [Abstract][Full Text] [Related]
20. Bile Acids and Microbiota: Multifaceted and Versatile Regulators of the Liver-Gut Axis. Grüner N; Mattner J Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]